Madden Erin Fanning, Frabis Felicia, Cohn Jonathan, Qeadan Fares, Mann Christopher Rc, Greenwald Mark K
Department of Family Medicine and Public Health Sciences, Wayne State University School of Medicine, 540 E. Canfield Ave, Detroit, MI 48201, United States.
Department of Internal Medicine, Wayne State University School of Medicine, 540 E. Canfield Ave., Detroit, MI 48201, United States.
Drug Alcohol Depend Rep. 2024 Jul 14;12:100259. doi: 10.1016/j.dadr.2024.100259. eCollection 2024 Sep.
Stigma enacted in primary care settings remains a barrier to care for people who use drugs (PWUD). Little is known about the acceptability of potential stigma interventions to target structural drivers of stigma affecting the organizational- or provider-level.
In-depth interview data were collected from 21 individuals working in Michigan primary care facilities. Participants included clinical (e.g., physicians, nurses) and non-clinical (e.g., administrators, receptionists) staff. Interviews explored perceptions of stigma toward PWUD and the acceptability of interventions to mitigate such stigma. Thematic analysis was used to identify stigma themes.
Participants largely reported substance-use stigma as a matter of individual attitudes or knowledge limitations and described such stigma as rarely occurring during interpersonal interactions. Participants were still acutely aware of upstream societal and organizational factors creating structural barriers to care and/or worsening outcomes among PWUD, but seldom labeled these as stigma. Some provider and structural stigma reduction interventions were enthusiastically supported because they address participant ideas of substance-use stigma drivers (e.g., lack of knowledge) or provide resources that could improve care quality or provide resources for PWUD. Conversely, participants opposed some potential stigma interventions, e.g., less-frequent urine drug testing and increasing clinical visit time, deemed infeasible because of outside forces like insurers or regulators.
Although most participants conceptualized substance-use stigma as an individual or interpersonal process best addressed with training, their awareness of social determinants of health seemed to fuel an openness to some structural interventions to reduce organizational and provider stigma toward PWUD in primary care settings.
在初级保健机构中存在的污名化现象仍然是吸毒者获得护理的障碍。对于针对影响组织或提供者层面污名化的结构性驱动因素的潜在污名化干预措施的可接受性,人们知之甚少。
从密歇根州初级保健机构工作的21名人员那里收集了深入访谈数据。参与者包括临床(如医生、护士)和非临床(如管理人员、接待员)工作人员。访谈探讨了对吸毒者的污名化认知以及减轻此类污名化干预措施的可接受性。采用主题分析法来确定污名化主题。
参与者大多将药物使用污名化视为个人态度或知识局限问题,并将这种污名化描述为在人际互动中很少发生。参与者仍然敏锐地意识到上游社会和组织因素给吸毒者造成了获得护理的结构性障碍和/或使结果恶化,但很少将这些因素称为污名化。一些减少提供者和结构性污名化的干预措施得到了热情支持,因为它们解决了参与者关于药物使用污名化驱动因素的想法(如知识缺乏),或者提供了可以提高护理质量的资源或为吸毒者提供资源。相反,参与者反对一些潜在的污名化干预措施,例如减少尿液药物检测频率和增加临床就诊时间,认为由于保险公司或监管机构等外部力量,这些措施不可行。
尽管大多数参与者将药物使用污名化概念化为一个最好通过培训来解决的个人或人际过程,但他们对健康社会决定因素的认识似乎促使他们对一些结构性干预措施持开放态度,以减少初级保健机构中对吸毒者的组织和提供者污名化。